Related Experiment Video
Updated: Aug 8, 2026

Assessment of Kidney Function in Mouse Models of Glomerular Disease
Published on: June 30, 2018
Microalbuminuria and essential hypertension: renal and cardiovascular implications
1Franz Volhard Clinic, Berlin, Germany. fcluft@orion.rz.mdc-berlin.de
Abstract:
Microalbuminuria continues to receive attention in patients with hypertension, even if they do not have diabetes mellitus. The attention appears deserved, because microalbuminuria has emerged as an important risk factor for left ventricular hypertrophy, myocardial infarction, stroke, peripheral vascular disease and retinopathy, independent of blood pressure. Microalbuminuria may be a useful measurement during pregnancy and appears particularly indicated in following up women who develop pre-eclampsia during pregnancy. In addition to diabetes, increased blood pressure and age, the smoking habit appears to be the most important factor contributing to microalbuminuria, although other influences including uranium exposure have been implicated. We need to learn more about the mechanisms of microalbuminuria, particularly in non-diabetic hypertensive patients. Microalbuminuria is potentially reversible. All antihypertensive agents appear to reduce microalbuminuria. In diabetic patients, angiotensin-converting enzyme inhibitor therapy is effective in reducing renal disease progression, even in the absence of hypertension. Antioxidant therapy may be effective. Stopping smoking should be the initial antioxidant measure.
Insights
Microalbuminuria is a significant risk factor for cardiovascular issues in hypertensive patients without diabetes. Prompt intervention, including smoking cessation and antihypertensive therapy, can help manage and potentially reverse this condition.
Area of Science:
- Nephrology
- Cardiology
- Hypertension Research
Background:
- Microalbuminuria is increasingly recognized in hypertensive patients without diabetes.
- It serves as an independent risk factor for serious cardiovascular and microvascular complications.
- Its role in pregnancy, particularly with pre-eclampsia, warrants attention.
Purpose of the Study:
- To highlight the significance of microalbuminuria in non-diabetic hypertensive individuals.
- To identify key contributing factors and potential therapeutic strategies.
- To emphasize the reversibility of microalbuminuria.
Main Methods:
- Observational analysis of microalbuminuria prevalence and associated risk factors.
- Review of existing literature on therapeutic interventions.
- Assessment of microalbuminuria as a predictor of cardiovascular events.
Main Results:
- Microalbuminuria is linked to left ventricular hypertrophy, myocardial infarction, stroke, peripheral vascular disease, and retinopathy.
- Smoking is a major contributor, alongside hypertension, age, and potentially uranium exposure.
- Antihypertensive agents and smoking cessation show promise in reducing microalbuminuria.
Conclusions:
- Microalbuminuria is a critical marker in hypertensive patients, irrespective of diabetes status.
- Early detection and intervention, including lifestyle changes like smoking cessation and appropriate medical therapy, are crucial.
- Further research into the mechanisms of microalbuminuria in non-diabetic hypertensives is needed.
More Related Videos
11:47Using 2-Photon Microscopy to Quantify the Effects of Chronic Unilateral Ureteral Obstruction on Glomerular Processes
Published on: March 4, 2022
10:31Comparative Proteomic Analysis of Whole Kidney, Medulla, and Cortical Tubules in Diabetic Pathogenesis of Kidney Injury in Mice
Published on: May 2, 2025
Related Concept Videos
Hypertension and Regulation of Blood Pressure
Hypertension III: Clinical Manifestations and Diagnostic Studies
Nephrotic Syndrome I : Introduction
Nephrotic Syndrome II : Assessment and Medical Management
Chronic Kidney Disease I: Introduction
Diabetic Nephropathy